文献速递泌尿男性生殖肿瘤

破坏SUV39H1介导的H3K9甲基化维持CAR T细胞功能

Disruption of SUV39H1-Mediated H3K9 Methylation Sustains CAR T-cell Function.
PubMed 文献 · Cancer Discov · 2024-01-01

基于CD28的CAR T细胞效应功能强但寿命有限。在白血病和前列腺癌模型中,基因破坏SUV39H1可增强人CAR T细胞的早期扩增、长期存续和总体抗肿瘤疗效,并改善反复再攻击后的扩增和肿瘤排斥,减少抑制性受体表达并限制耗竭。

要点

  • 破坏SUV39H1增强CAR T细胞在白血病和前列腺癌模型中的早期扩增与长期存续。
  • SUV39H1编辑的CAR T细胞在多次再攻击后扩增和肿瘤排斥改善。
  • SUV39H1编辑降低抑制性受体表达并限制多次再攻击后的耗竭。

核心结论

  • 表观遗传编程破坏SUV39H1介导的组蛋白沉默程序可促进基于CD28的CAR T细胞的功能存续。

研究设计与样本

  • 在人CAR T细胞中基因破坏SUV39H1,并在白血病和前列腺癌模型中进行功能验证。

主要发现

  • SUV39H1破坏增强人CAR T细胞在白血病和前列腺癌模型中的早期扩增、长期存续和总体抗肿瘤疗效。
  • 存续的SUV39H1编辑CAR T细胞在多次再攻击后显示扩增和肿瘤排斥改善。
  • 反复攻击的CAR T细胞转录和基因组可及性分析显示SUV39H1编辑CAR T细胞中记忆转录因子的表达和可及性改善。
  • SUV39H1编辑降低抑制性受体表达并限制多次再攻击后CAR T细胞的耗竭。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Suboptimal functional persistence limits the efficacy of adoptive T-cell therapies. CD28-based chimeric antigen receptors (CAR) impart potent effector function to T cells but with a limited lifespan. We show here that the genetic disruption of SUV39H1, which encodes a histone-3, lysine-9 methyl-transferase, enhances the early expansion, long-term persistence, and overall antitumor efficacy of human CAR T cells in leukemia and prostate cancer models. Persisting SUV39H1-edited CAR T cells demonstrate improved expansion and tumor rejection upon multiple rechallenges. Transcriptional and genome accessibility profiling of repeatedly challenged CAR T cells shows improved expression and accessibility of memory transcription factors in SUV39H1-edited CAR T cells. SUV39H1 editing also reduces expression of inhibitory receptors and limits exhaustion in CAR T cells that have undergone multiple rechallenges. Our findings thus demonstrate the potential of epigenetic programming of CAR T cells to balance their function and persistence for improved adoptive cell therapies. SIGNIFICANCE: T cells engineered with CD28-based CARs possess robust effector function and antigen sensitivity but are hampered by limited persistence, which may result in tumor relapse. We report an epigenetic strategy involving disruption of the SUV39H1-mediated histone-silencing program that promotes the functional persistence of CD28-based CAR T cells. See related article by López-Cobo et al., p. 120. This article is featured in Selected Articles from This Issue, p. 5.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Jain N, Zhao Z, Koche RP, et al. Disruption of SUV39H1-Mediated H3K9 Methylation Sustains CAR T-cell Function. Cancer Discov. 2024. PMID: 37934007. doi:10.1158/2159-8290.CD-22-1319

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。